Recent News

• 03.07.2025 - Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting
• 03.07.2025 - Oruka Therapeutics Announces Preclinical Data for ORKA-002 at the 2025 American Academy of Dermatology Annual Meeting
• 03.06.2025 - Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
• 03.06.2025 - Oruka Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference
• 03.04.2025 - TD Cowen 45th Annual Health Care Conference

Recent Filings

• 03.06.2025 - S-8 Securities to be offered to employees in employee benefit plans
• 03.06.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.06.2025 - POS AM Post-Effective amendments for registration statement
• 02.27.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.27.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.27.2025 - 3 Initial statement of beneficial ownership of securities
• 02.05.2025 - 8-K Current report
• 01.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 01.24.2025 - 4 Statement of changes in beneficial ownership of securities